In
this issue...
Envision, Inc. and APIC to release New Programs on Patient
Safety, Hand Hygiene, and IV Guidelines.
Three new programs from Envision, Inc. and APIC to help meet
your educational and infection control needs:
Patient
Safety: A Top Priority!
This NEW program covers JCAHO and
CMS Guidelines making patient safety a top priority! Highlighted are
the most common types and sources of errors, reporting criteria,
disclosure and much more!
Hand
Hygiene: New Guidelines is a comprehensive training program
that identifies hand hygiene practices which provide protection
against the transmission of infectious agents.
New
Guidelines for the Prevention of Intravascular Infections is
a program that focuses on the critical issues surrounding IV
infections and strategies for prevention.
INTERESTING NEWS
CDC
says blood transfusion can spread West Nile virus
West
Nile virus Threatens Those with Weak Immune Systems, such as People
with HIV/AIDS
Hepatitis B 100
times easier to catch than HIV!
University
of Tennessee taking part in study to help cut
infections
Pennsylvania
Health Department Announces Investigation of Listeria
Infections
Organ
Transplants Successful for HIV-Positive Patients
Price
of Passion
Virax
to Develop Hepatitis B Treatment with New York Blood
Center
Quick Links...
|
| Greetings!
With Infection Control Week fast approaching, we
are pleased to release this edition of our E-newsletter
focused specifically on Infection Control issues. Envision,
Inc. is very proud of the longstanding affiliation we have
with APIC in bringing credible infection control programs to
educators everywhere. In this issue, you will find sections on
interesting news, quick links with training tips and
resources, information on Infection Control Week and
articles on one of the hottest topics of today... the
West Nile virus.
Welcome to our new subscribers and thanks again to those
who continue to show support by forwarding the newsletter to
your colleagues and submitting your training tips and
suggestions.
At Envision, Inc., we strive to bring you
the latest information and tools to help meet your educational
needs. Each edition of our E-newsletter will be filled with
the most current news and tips on a chosen subject. The next
E-newsletter will focus on the topic of Restraint Reduction
and Fall Prevention.
We'd like to invite you to
submit your ideas for the Training Tips and Resources
section of the upcoming December edition. Simply contact
us toll free 866-321- 5066 or via email at
education@EnvisionInc.net
|
Infection Control Week: October
21-27
 Infection control is an
effort shared by every healthcare provider--and one that
begins on the individual level. APIC is committed to
influencing, supporting, and improving the quality of
healthcare through the practice and management of infection
control and the application of epidemiology in all health
settings. It is with this mission in mind that each year
during the third week of October, APIC promotes the practice
of infection control through International Infection Control
Week.
For
more information...
»
|
|
Avoid Mosquito Bites to Avoid Infection
 Human illness from the West
Nile virus is rare, even in areas where the virus has been
reported. The chance that any one person is going to become
ill from a mosquito bite is low. You can further reduce your
chances of becoming ill by protecting yourself from mosquito
bites.
To avoid mosquito bites:
Apply insect
repellent containing DEET (N, N-diethyl-meta-toluamide) when
you're outdoors. For details on when and how to apply
repellent, see...
Read
on...
»
|
|
Alcohol Gels Top Soap for Hand Hygiene at Hospitals
 Hospital workers might say
so long to good old soap-and-water scrubbing, as new research
finds that alcohol-based gels are an easier, more effective
way to disinfect dirty hands, experts say. And while the
alcohol rubs cost more up front, they can save money over time
by cutting down on potentially serious hospital-acquired
infections that can total thousands of dollars to treat,
according to research presented here Saturday at a meeting of
the American Society for Microbiology.
Full
Story...
»
|
|
Inhibitex, Inc. Initiates Phase I Study of Veronate for
the Prevention of Staphylococcal Infections in Premature
Infants
 Inhibitex, Inc. a
biopharmaceutical company focused on the prevention and
treatment of staphylococcal and other bacterial infection,
announced the start of a Phase I clinical trial of its lead
product, the start of a Phase I clinical trial of its lead
product, Veronate, for the prevention of staph infections in
premature infants. Inhibitex is developing Veronate (TM) to
reduce the risk of both Staphylococcus aureus (S. aureus) and
coagulase-negative staphylococcal infections in very low birth
weight infants.
A recent study conducted by...
Full
Story...
»
| |
